Abstract
In the term of “chronic ischemic heart disease” a series of different nosological, physiopathologic and etiological forms are included, which can differ even considerably in their therapy. Among these, stable, unstable, variant and microvascular angina are the most common, as well as the various forms in which chest pain is absent or is not the main symptom, such as “silent” ischemic heart disease and the arrhythmic or congestive forms. While at present the causes of microvascular angina are not well known, the forms affecting large epicardial vessels are mostly due to coronary atherosclerosis, although arterial diseases caused by different etiologies (infectious, dysreactive, malformative) may occasionally be involved. Therefore, from the point of view of both practical feasibility and interest due to incidence, the prevention of chronic ischemic heart disease actually coincides with atherosclerosis prevention.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Howard, A.N., Patelski, J., Bowyer, D.E. and Gresham, G. A. (1971) ‘Atherosclerosis induced in hypocholesterolaemic baboons by immunological injury and the effects of i/v polyunsaturated phosphatidyl choline’, Atherosclerosis, 14, 17.
Muir, C., Taylor, T.G. and Munday K.A. (1977) ‘An investigation in rabbits of the immunological theory of atherogenesis’, Proc. Nutr.Soc., 36, 95A.
Beaumont, J.L. and Beaumont, V. (1977) ‘Autoimmune hyperlipidemia’, Atherosclerosis, 26, 405.
Muscari, A., Bozzoli, C., Gerratana, C., Zaca’, F., Rovinetti, C., Zauli, D., La Placa, M., and Puddu, P. (1988) ‘Association of serum IgA and C4 with severe atherosclerosis, Atherosclerosis, 74, 179.
Annand, J.C. (1967) ‘Hypothesis: heated milk protein and thrombosis’, J. Atheroscler. Res., 7, 797.
Davies, D.F., Davies, J.R. and Richards, M.A. (1969) ‘Antibodies to reconstituted dried cow’ss milk protein in coronary heart disease’, J. Atheroscler. Res., 9, 103.
Ross., J. and Oster, K.A. (1975) “Milk-protein antibodies and myocardial infarction”, Lancet, ii, 1037.
Toivanen, A., Viljanen, M.K. and Savilhati, E. (1975) ‘IgM and IgG anti-milk antibodies measured by radioimmunoassay in myocardial infarction’, Lancet, ii, 205.
Gibney, M.J., Gallagher, P.J., Sharratt, G.P., Benning, H. S. Taylor, G. and Pitts, J.M. (1980) ‘Antibodies to heated milk protein in coronary heart disease’, Atherosclerosis, 53, 119.
Muscari, A., Volta, U., Bonazzi, C., Puddu, G.M., Bozzoli, C.f Gerratana, C., Bianchi, F.B. and Puddu, P. (1989) ‘Association of serum IgA antibodies to milk antigens with severe atherosclerosis’, Atherosclerosis, 77, 251.
Levinsky, R.J. and Barratt,T.M. (197 9) ‘IgA immune complexes in Henoch-Schonlein purpura’, Lancet., ii, HOC).
Triolo, G., Giardina, E.f Rinaldi, A. and Bompiani, G.D. (1984) ‘IgA- and insulin-containing (C3-fixing) circulating immune complexes in diabetes mellitus’, Clin. Immunol. Immunopathol., 30, 169.
Beaumont, J.L., Doucet, F.f Vivier, P. and Antonucci, M. (1989) ‘Immunoglobulin-bound lipoproteins (Ig-Lp) as markers of familial hypercholesterolemia, xanthomatosis and atherosclerosis’, Atherosclerosis, 74, 191.
Klimov, A.N., Denisenko, A.D., Vinogradov, A.G., Nagornev, V.A., Pivovarova, Y.D., Sitnikova, O.D. and Pleskov, V.M. (1988) ‘Accumulation of cholesteryl esters in macrophages incubated with human lipoprotein- antibody autoimmune complex’, Atherosclerosis, 74, 41.
Brown, M.S. and Goldstein, J.L. (198 3) ‘Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis’, Annu. Rev. Biochem., 52, 223.
Swartz, G.M.Jr., Gentry, M.K., Amende, L.M., Blanchette-Mackie, E.J. and Alving, C,R. (1988) ‘Antibodies to cholesterol’, Proc. Natl. Acad. Sci. USA, 85, 1902.
Hammerschmidt, D.E., Greenberg, C.S., Yamada, O., Craddock, P.R. and Jacob, H.S. (1981) ‘Cholesterol and atheroma lipids activate complement and stimulate granulocytes. A possible mechanism for amplification of ischemic injury in atherosclerotic states’, J. Lab. Clin. Med., 98, 68.
Ferrini, D., Bugiardini, R., Galvani, M., Gridelli, C., Tollemeto, D. and Puddu P. (1986) ‘Opposing effects of propranolol and diltiazem on the angina threshold during an exercise test in patients with syndrome X’, G. Ital. Cardiol., 16, 1224.
Bugiardini, R., Borghi, A., Biagetti, L. and Puddu, P. (1989) ‘Comparison of verapamil versus propranolol therapy in syndrome X’, Am. J. Cardiol., 63, 286.
Lee, D.D-P., Kimura, S.T De Quattro, V. (1989) ‘Noradrenergic activity and silent ischemia in hypertensive patients with stable angina: effect of metoprolol’, Lancet, i, 403.
Braunwald, E. and Rutherford, J.D. (1986) ‘Reversible ischemic left ventricular dysfunction: evidence for the “hibernating myocardium”’, J. Am. Coll. Cardiol., 8, 1467.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Puddu, P., Puddu, G.M., Bozzoli, C., Muscari, A. (1990). Chronic ischemic heart disease: prevention and therapy. In: Descovich, G., Gaddi, A., Magri, G., Lenzi, S. (eds) Atherosclerosis and Cardiovascular Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0731-7_72
Download citation
DOI: https://doi.org/10.1007/978-94-009-0731-7_72
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6814-7
Online ISBN: 978-94-009-0731-7
eBook Packages: Springer Book Archive